Eli Lilly has entered a $2.75 billion partnership with InSilico Medicine to enhance AI-driven drug discovery, promising rapid advancements in pharmaceuticals.
Japan’s yen is under pressure, prompting officials to consider intervention and potential rate hikes to stabilize the currency amidst global economic uncertainties.
Vedanta is set to split into five companies, aiming to unlock shareholder value and improve operational efficiency. This strategic move is expected to enhance growth opportunities.